Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

582
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
582
Survival Curves01:18

Survival Curves

299
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
299
Survival Tree01:19

Survival Tree

153
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
153
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

381
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
381
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

277
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
277
Statistical Hypothesis Testing01:16

Statistical Hypothesis Testing

2.1K
Hypothesis testing is a critical statistical procedure facilitating informed, evidence-based decisions. It begins with a hypothesis, which is a tentative explanation, or a prediction about a population parameter. This hypothesis can be either a null hypothesis (H0), indicating no effect or difference, or an alternative hypothesis (Ha), suggesting an effect or difference.
Statistical significance measures the probability that an observed result occurred by chance. If this probability, known as...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new trigonometric modification of the Weibull distribution: Control chart and applications in quality control.

PloS one·2023
Same author

Bivariate power Lomax distribution with medical applications.

PloS one·2023
Same author

Statistical modeling for COVID 19 infected patient's data in Kingdom of Saudi Arabia.

PloS one·2022
Same author

Statistical modelling for a new family of generalized distributions with real data applications.

Mathematical biosciences and engineering : MBE·2022
Same author

Statistical Modeling of Some Cancerous Diseases Using the Laplace Transform Approach of Basic Life Testing Issues.

Computational and mathematical methods in medicine·2022
Same author

A New Model of Discrete-Continuous Bivariate Distribution with Applications to Medical Data.

Computational and mathematical methods in medicine·2022

Related Experiment Video

Updated: Sep 5, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Modeling Various Survival Distributions using a Nonparametric Hypothesis Testing Based on Laplace Transform Approach

A M Gadallah1, B I Mohammed2, Abdulhakim A Al-Babtain3

  • 1Department of Basic Sciences, Thebes Higher Institute for Engineering, Thebes Academy, Cairo, Egypt.

Computational and Mathematical Methods in Medicine
|July 8, 2022
PubMed
Summary

This study introduces a new statistical test to evaluate medical treatments using survival data. The test is effective when survival data exhibits the new better than used (NBU 2) property, indicating potential treatment benefits.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K

Related Experiment Videos

Last Updated: Sep 5, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K

Area of Science:

  • Statistics
  • Biostatistics
  • Survival Analysis

Background:

  • Assessing medical treatment effectiveness requires robust statistical methods.
  • Survival data analysis is crucial for understanding patient outcomes.
  • Existing nonparametric tests may have limitations in certain data distributions.

Purpose of the Study:

  • To develop and validate a novel nonparametric statistical test for evaluating processing methodologies or system effectiveness.
  • To assess the utility of the new better than used (NBU 2) property in survival data analysis for treatment evaluation.
  • To compare the performance of the proposed test against existing methods.

Main Methods:

  • Employed a second-order approach based on the new better than used (NBU 2) property.
  • Analyzed survival data, considering both NBU 2 and exponential distributions.
  • Calculated the power and efficiency of the proposed test for complete and censored data.
  • Compared the proposed test with existing statistical tests.
  • Applied the test to real-world datasets.

Main Results:

  • The proposed test is effective when survival data follows the NBU 2 property, suggesting potential treatment benefits.
  • When survival data is exponential, the test indicates no significant influence of the treatment method.
  • The test demonstrated valid performance in terms of power and efficiency on both complete and censored data.

Conclusions:

  • The developed nonparametric statistical test, utilizing the NBU 2 property, offers a valuable tool for assessing treatment effectiveness.
  • The test's performance is reliable across different data censoring scenarios.
  • This approach provides a method to determine if a treatment method positively influences patient survival based on data distribution.